BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18993081)

  • 21. A scarlet letter or a red herring?
    Nowlan WJ
    Nature; 2003 Jan; 421(6921):313. PubMed ID: 12540874
    [No Abstract]   [Full Text] [Related]  

  • 22. Bridging the gap between life insurer and consumer in the genetic testing era: the RF proposal.
    Keefer CM
    Indiana Law J; 1999; 74(4):1375-95. PubMed ID: 16211754
    [No Abstract]   [Full Text] [Related]  

  • 23. Estonian parliament considers genome law.
    Lähteenmaki R
    Nat Biotechnol; 2000 Nov; 18(11):1135. PubMed ID: 11062422
    [No Abstract]   [Full Text] [Related]  

  • 24. Advocates, legislators gear up for battle in the fight to keep genetic information, testing secure from employers, insurers.
    Benko LB
    Mod Healthc; 2007 Apr; 37(14):6-7, 12, 14 passim. PubMed ID: 17444260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethical and legal aspects of cancer genetic testing.
    Offit K; Thom P
    Semin Oncol; 2007 Oct; 34(5):435-43. PubMed ID: 17920900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic testing in assisted reproduction.
    Fruchtman CE; Lieber C
    Hastings Cent Rep; 2003; 33(6):11; discussion 11-2. PubMed ID: 14983553
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetic discrimination. Long-awaited genetic nondiscrimination bill headed for easy passage.
    Holden C
    Science; 2007 May; 316(5825):676. PubMed ID: 17478690
    [No Abstract]   [Full Text] [Related]  

  • 28. [BRCA1: from the gene identification to the cancer risk estimation].
    Stoppa-Lyonnet D; Jeanpierre M
    Med Sci (Paris); 2004 Mar; 20(3):262-3. PubMed ID: 15067565
    [No Abstract]   [Full Text] [Related]  

  • 29. Crunch time for multiple-gene tests.
    Gewin V
    Nature; 2007 Jan; 445(7126):354-5. PubMed ID: 17251949
    [No Abstract]   [Full Text] [Related]  

  • 30. Disparities in BRCA testing: when insurance coverage is not a barrier.
    Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
    Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic discrimination: why Bragdon does not ensure protection.
    Rothstein LF
    J Health Care Law Policy; 2000; 3(2):330-51. PubMed ID: 15015483
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetics and childhood cancer. Commentary on: inherited cancer in children: practical/ethical problems and challenges.
    Ross JA
    Eur J Cancer; 2004 Nov; 40(16):2471-2. PubMed ID: 15519521
    [No Abstract]   [Full Text] [Related]  

  • 33. GINA, aGAIN.
    Nat Genet; 2007 Feb; 39(2):133. PubMed ID: 17262018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial distribution of patient population and family physician endorsed importance of screening patients for inherited predisposition to cancer.
    Gramling R; Clarke J; Simmons E
    J Health Care Poor Underserved; 2009 Feb; 20(1):50-4. PubMed ID: 19202245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic testing and discrimination: how private is your information?
    Slaughter LM
    Stanford Law Pol Rev; 2006; 17(1):67-81. PubMed ID: 17165231
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
    Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
    Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer genetic testing: current and emerging issues.
    Patenaude AF; Julian-Reynier C
    Psychooncology; 2008 Aug; 17(8):733-6. PubMed ID: 18688786
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetically modified cells, or how some cancers occur.
    Bentley P
    Nurs Times; 1999 Nov 3-9; 95(44):48-9. PubMed ID: 10983082
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic oncology testing is complex, but coverage and reimbursement don't have to be.
    James LP
    Am J Manag Care; 2019 Aug; 25(9 Spec No.):SP288-SP289. PubMed ID: 31442013
    [No Abstract]   [Full Text] [Related]  

  • 40. The social response to genetic conditions: beware of the antidiscrimination law.
    Epstein RA
    Health Aff (Millwood); 2007; 26(5):1249-52. PubMed ID: 17848433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.